Ophthalmology Market Research Reports & Industry Analysis
Ophthalmology Industry Research & Market Reports
-
2025 Ophthalmic Goods Wholesale Global Market Size & Growth Report with Updated Analysis & Forecasts
... and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies with wholesale sales of ophthalmic goods. The survey ... Read More
-
2025 Diseases of the Eye and Adnexa Global Market Size & Growth Report with Updated Analysis & Forecasts
... East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the eye ... Read More
-
Cataract Surgical Devices Market Report by Product Type (Ophthalmic viscoelastic devices (OVDs), Intraocular lenses (IOLs), Femtosecond laser, Phacoemulsification equipment, and Others), End-Use (Hospitals, Eye care clinics, Eye Treatment and Surgical Centres), and Region 2025-2033
... 2025-2033. The growing number of cataract cases, the introduction of sophisticated devices, such as femtosecond lasers and phacoemulsification systems, the growing global healthcare expenditure and the improved access to healthcare services represent some of the ... Read More
-
RNA Interference (RNAi) Drug Delivery Market Report by Application (Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others), Technology (Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, Aptamer Drug Delivery), and Region 2025-2033
... 17.75% during 2025-2033. Ribonucleic acid interference (RNAi) drug delivery refers to a therapeutic solution to monitor gene expression or mutations. RNAi drug delivery is usually administered through intravenous, intra-dermal and intraperitoneal injections and topical delivery ... Read More
-
Non-Infectious Macular Edema Treatment
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Anti-VEGF Drug, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$16.6 Billion by the ... Read More
-
Lacrimal Duct Stent Tubes
... 2030, growing at a CAGR of 2.1% over the analysis period 2024-2030. Bicanalicular Tubes, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$35.0 Million by the ... Read More
-
Aesthetic Ophthalmology Devices
... at a CAGR of 7.9% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$837.6 Million by the end of ... Read More
-
Retinal Laser Equipment
... at a CAGR of 7.1% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$693.0 Million by the end of ... Read More
-
Eye Allergy Therapeutics
... at a CAGR of 5.5% over the analysis period 2024-2030. Antihistamines, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Energy-based Therapeutics
... CAGR of 3.6% over the analysis period 2024-2030. Laser-based Technology, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Retinal Implants
... CAGR of 7.1% over the analysis period 2024-2030. Implantable Miniature Telescope, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$34.4 Million by the end of the ... Read More
-
Ocular Prosthesis
... CAGR of 6.6% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion by the end of the analysis ... Read More
-
Diabetic Macular Edema Treatment
... 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Anti-VEGF, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$2.7 Billion by the end ... Read More
-
Neuroprosthetics
... 11.9% over the analysis period 2024-2030. Spinal Cord Stimulation Technique, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$11.7 Billion by the end of the analysis ... Read More
-
Ophthalmic Femtosecond Lasers
... at a CAGR of 4.6% over the analysis period 2024-2030. Ophthalmic Femtosecond Laser Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$666.4 Million ... Read More
-
Ophthalmic Lasers
... CAGR of 5.0% over the analysis period 2024-2030. Femtosecond Lasers, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$757.4 Million by the end of the analysis ... Read More
-
Ophthalmic Pharmaceutical Drugs
... at a CAGR of 3.6% over the analysis period 2024-2030. Anti-VEGF Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$34.3 Billion by the end of ... Read More
-
Glaucoma Therapeutics
... CAGR of 3.5% over the analysis period 2024-2030. Prostaglandins Analogs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.9 Billion by the end of the analysis ... Read More
-
Vitreous Tamponades
... CAGR of 3.0% over the analysis period 2024-2030. Gaseous Tamponades, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$50.9 Million by the end of the analysis ... Read More
-
Ophthalmic Ultrasound Systems
... at a CAGR of 3.9% over the analysis period 2024-2030. Portable Systems, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by the end of ... Read More
-
Glaucoma Surgery Devices
... at a CAGR of 21.0% over the analysis period 2024-2030. Traditional Surgery, one of the segments analyzed in the report, is expected to record a 20.8% CAGR and reach US$3.1 Billion by the end of ... Read More
-
Eylea Global Market Opportunities And Strategies To 2033
... Bayer AG; Biocon Biologics Limited; Samsung Bioepis Co. Ltd.; Amgen Biosimilar Inc. Eylea Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical ... Read More
-
Global Ophthalmology Packaging Market - 2025 - 2033
... during the forecast period 2025-2033. Ophthalmology packaging refers to specialized packaging solutions designed for eye care products such as medications, medical devices, and surgical instruments. This field includes the design, manufacture, and distribution of packaging ... Read More
-
2025 Global Forecast for Contact Lenses For Presbyopia Market (2026-2031 Outlook)-High Tech Outlook Report
... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More
-
2025 Global: Corneal Edema Treatment Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
Research Assistance
